Table 2 All of the reported cytokines/chemokines abnormalities during SLE progression among Iranian patients
From: Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview
Study (et al.) | Year | Gene | Population | Results |
|---|---|---|---|---|
Sedighi [37] | 2014 | IL-2 | 73 NCa 73 SLEb | IL-2 was significantly correlated with Prednisone consumption |
Mohammadi [61] | 2019 | IL-17 | 20 NC 40 SLE | Increased IL-17 levels is SLE patients receiving glucocorticoids |
Rastin [66] | 2016 | IL-6‚ IL-17, IFN-γ | 40 SLE | IL-17, IL-6, and IFN-γ up regulations |
Aghdashi [69] | 2013 | IL-18 | 25 NC 25 SLE | Serum levels of IL-18 were correlated with platelet counts and C3 levels |
Jafari-Nakhjavani [71] | 2016 | IL-18 | 50 NC 113 SLE | Increased serum levels of IL-18 |
Loghman [73] | 2016 | Adiponectin | 50 SLE | Increased urinary levels of adiponectin |
Sahebari [80] | 2012 | Fas, IL-18 | 50 NC 114 SLE | Increased serum levels of Fas and IL-18 |
Hatef [81] | 2013 | IL-18, Fas | 46 NC 32 SLE | Increased serum levels of Fas and IL-18 |
Abediazar [128] | 2019 | CXCL10 | 39 NC 25 SLE | Increased levels of CXCL10 |
Hajialilo [142] | 2018 | VCAM-1, ET-1 | 40 NC 60 SLE | Up regulations of serum VCAM-1 and ET-1 |
Yazdanpanah [167] | 2017 | TLR3, TLR7, TLR9 | 20 NC 20 SLE | TLR7 and TLR9 up-regulations |
Mortezagholi [169] | 2016 | TLR9 | 38 NC 35 SLE | Increased expression of TLR9 |